Status:
UNKNOWN
Clinical Value of Plasma Humanin in Acute Kidney Injury
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to assess the clinical value of humanin in acute kidney injury. The main questions it aims to answer are:whether Humanin can be a novel marker for predicting AK...
Detailed Description
Acute Kidney Injury (AKI) is a clinically critical condition manifested by a sharp decline in kidney function, with approximately 13.3 million people diagnosed with AKI each year in hospital worldwide...
Eligibility Criteria
Inclusion
- Adult patients ≥ 18 years of age, male or female；
- Patients with AKI: Patients with acute kidney injury who meet the definition of KDIGO guidelines；
- Control group: from healthy physical examination population, physical examination blood routine, urine routine, liver function, kidney function, glycated hemoglobin and other indicators are normal；
- The patient's baseline medical record data is complete, including liver and kidney function, urine protein level, blood creatinine value, etc；
- Consent to enrollment and sign informed consent；
Exclusion
- Age\< 18 years；
- Baseline data were missing
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06105229
Start Date
August 1 2022
End Date
June 1 2024
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial People's Hospital
Guangdong, Guangzhou, China, 510000